&A) Consolidated Financial Results For The Year 2018 For the year ended December 31st, 2018 Consolidated Profit & Loss of NPPG (THAILAND) PCL., Unit : Million Thai Baht (THB) Y 2018 Y 2017 Change %YoY
11.98 0.28 2.35 8.99 300.90 Net Profit /(Loss) 1.86 3.10 13.76 10.66 343.87 11.90 640.98 Gross Profit Margin (%) 8.66 18.73 20.08 1.35 7.23 11.42 131.99 Net Profit Margin (%) 0.87 1.23 5.07 3.83 310.58
contracts (917.54) (576.04) 341.50 59.28 Gross profit 101.75 75.25 26.50 35.21 Other income 2.69 4.25 (1.56) (36.63) Profit before expense 104.44 79.50 24.94 31.37 Administrative expensed (58.54) (50.42) 8.12
profit per share in 2019 was 0.019. In 4Q/2019 the Company had consolidated net loss of THB 129.0mn, a decrease of THB 233.0mn, or 224.0% YoY from net profit of THB 104.0mn in 4Q/2018. Net loss per share
. Ended May 31, 2017, audited by auditors. The details are as follows 1. The Company's total revenue is Baht 1,145. 18 million, a decrease of Baht 80 . 8 2 million or 6. 59% from the same period of last
million decreased by 93% compared to a net profit of Baht 84.10 million for the same period of previous year from decline in total sales volumes of zinc and the continuous decrease in LME Zinc price during
. (3) Gross profit The Company and its subsidiaries’ total gross profit were Baht 45.01 million, which decreased from the same period of previous year by Baht 34. 78 million or 339. 84%, due to an
subsidiaries (14.60) (9.03) 0.05 Profit(Loss) attributable to equity holders of the company (68.68) (42.47) (9.41) (38.21) (59.27) 629.86 Basic Loss Per Share (THB) (0.09) (0.02) Book Value per Share (THB) 0.46
% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head